PRE vs CDNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

PRE

44.0
AI Score
VS
PRE Wins

CDNA

34.7
AI Score

Investment Advisor Scores

PRE

44score
Recommendation
HOLD

CDNA

35score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric PRE CDNA Winner
Forward P/E 0 25.1256 Tie
PEG Ratio 0 -0.12 Tie
Revenue Growth 210.7% 52.2% PRE
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 44.0/100 34.7/100 PRE
Profit Margin -30.4% 24.2% CDNA
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL PRE

Relative Price Performance (Last 90 Days)

PRE 1M: +16.4% · 3M: +30.1% CDNA 1M: +27.9% · 3M: +119.6%

Current Technical Phase

PRE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.9% over 20 days), RSI 64

RSI (14): 63.5 · Price: $21.82

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (34.3% over 20 days), RSI 67

RSI (14): 66.6 · Price: $47.50

Fundamentals Snapshot

Metric PRE CDNA
Market Cap
Forward P/E -23.2 35.1
Trailing P/E 23.4
Revenue (TTM)
Revenue Growth 2.1% 0.5%
Gross Margin 0.6% 0.7%
Operating Margin -0.5% 0.0%
EPS -3.46 2.08
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PRE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.